Efstathios Kastritis
MD
Associate Professor of Hematology
👥Biography 个人简介
Efstathios Kastritis was a principal investigator for the ANDROMEDA trial that established daratumumab subcutaneous as the standard-of-care foundation for frontline AL amyloidosis therapy. His work has also addressed organ response definitions, the impact of hematologic depth of response on organ recovery, and the management of amyloid patients with advanced cardiac or renal involvement. He publishes extensively on both WM and AL amyloidosis.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Efstathios Kastritis 的研究动态
Follow Efstathios Kastritis's research updates
留下邮箱，当我们发布与 Efstathios Kastritis（National and Kapodistrian University of Athens）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment